
Quotient Limited QTNT
Quarterly report 2023-Q3
added 05-23-2026
Quotient Limited Operating Cash Flow 2011-2026 | QTNT
Annual Operating Cash Flow Quotient Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -119 M | -77.6 M | -56.7 M | -75.7 M | -68.4 M | -56.2 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -56.2 M | -119 M | -75.6 M |
Quarterly Operating Cash Flow Quotient Limited
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -89.2 M | -64.3 M | -35.5 M | - | -96.2 M | -58.7 M | -32.1 M | - | -56.7 M | -30.6 M | -24.8 M | - | -64.8 M | -42.7 M | -25.1 M | - | -61.5 M | -41.1 M | -21.1 M | - | -61.5 M | -41.1 M | - | - | - | -19.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -19.1 M | -96.2 M | -48.1 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | ||
|
Agilent Technologies
A
|
1.48 B | $ 115.08 | 0.1 % | $ 35 B | ||
|
Celcuity
CELC
|
-153 M | $ 134.26 | -2.87 % | $ 6.28 B | ||
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-29.1 M | $ 9.11 | 79.68 % | $ 12.1 M | ||
|
Castle Biosciences
CSTL
|
64.3 M | $ 19.69 | -2.28 % | $ 571 M | ||
|
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-24.2 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | ||
|
Fulgent Genetics
FLGT
|
-102 M | $ 17.67 | 3.27 % | $ 544 M | ||
|
CareDx, Inc
CDNA
|
42 M | $ 21.54 | -0.42 % | $ 1.15 B | ||
|
Guardant Health
GH
|
-185 M | $ 119.85 | 0.76 % | $ 15 B | ||
|
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-46 K | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | ||
|
Interpace Biosciences
IDXG
|
5.83 M | $ 1.8 | -1.1 % | $ 7.96 M | ||
|
ICON Public Limited Company
ICLR
|
1.29 B | $ 113.85 | -2.51 % | $ 9.39 B | ||
|
Illumina
ILMN
|
837 M | $ 145.23 | 0.56 % | $ 23.1 B | ||
|
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-9.68 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | ||
|
Lantheus Holdings
LNTH
|
390 M | $ 100.06 | -2.85 % | $ 6.75 B | ||
|
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
738 M | $ 156.73 | -2.23 % | $ 7.77 B | ||
|
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | ||
|
Mettler-Toledo International
MTD
|
956 M | $ 1 101.33 | -0.16 % | $ 22.7 B | ||
|
Medpace Holdings
MEDP
|
713 M | $ 429.11 | -0.85 % | $ 12.4 B | ||
|
NeoGenomics
NEO
|
5.23 M | $ 9.27 | 0.43 % | $ 1.19 B | ||
|
National Research Corporation
NRC
|
26.4 M | $ 19.04 | -0.21 % | $ 426 M | ||
|
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | ||
|
Natera
NTRA
|
-432 M | $ 200.91 | -1.12 % | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
1.8 M | $ 3.85 | 0.79 % | $ 357 M | ||
|
Personalis
PSNL
|
-74.9 M | $ 8.94 | 5.55 % | $ 798 M | ||
|
Senseonics Holdings
SENS
|
-59.1 M | $ 6.43 | 1.42 % | $ 268 M | ||
|
QIAGEN N.V.
QGEN
|
654 M | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
46.8 M | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-3.84 M | $ 2.47 | -0.8 % | $ 5.67 M | ||
|
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 258.45 | -0.57 % | $ 21.5 B | ||
|
Twist Bioscience Corporation
TWST
|
-47.6 M | $ 64.87 | 7.1 % | $ 3.88 B | ||
|
Thermo Fisher Scientific
TMO
|
7.82 B | $ 448.18 | -0.02 % | $ 169 B | ||
|
Waters Corporation
WAT
|
653 M | $ 338.64 | -1.09 % | $ 20.2 B | ||
|
Trinity Biotech plc
TRIB
|
-4.19 M | $ 0.65 | 7.49 % | $ 233 M | ||
|
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
58.2 M | $ 9.14 | 2.7 % | $ 1.98 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 192.88 | -1.19 % | $ 21.4 B |